Books by Subject
- The global AIDS transition: a feasible objective for AIDS policy -- Using incentives to prevent HIV infections -- Sustaining and leveraging AIDS treatment -- Appendix A. Alternative approaches to estimating the average cost of antiretroviral treatment -- Appendix B. A meta-analysis of the health benefits of early initiation of antiretroviral therapy -- Appendix C. A model for projecting future AIDS treatment costs.
- Pt. 1. General properties of antimicrobial agents -- Pt. 2. Resistance to antimicrobial agents -- Pt. 3. General principles of usage of antimicrobial agents -- Pt. 4. Therapeutic use of antimicrobial agents.
- Antimicrobial drug resistance v. 1-2, 2009.Springerv. 2, 2009 Springerv. 1. Mechanisms of drug resistance -- v. 2. Clinical and epidemiological aspects.
- Mechanisms of resistance by gram-positive bacteria (streptococci and enterococci) / Javier Aspa Marco ... [et al.] -- Emergence of MRSA in the community / Adam L. Cohen, Rachel Gorwitz, and Daniel B. Jernigan -- Antimicrobial resistance to sexually transmitted infections / Hillard Weinstock, David Trees, and John Papp -- Resistance of gram-negative bacilli to antimicrobials / Patricia A. Bradford and Charles R. Dean -- Mycobacterial antimicrobial resistance / Peter D.O. Davies and Richard Cooke -- Antimicrobial resistance of anaerobic bacteria / Ellie J.C. Goldstein, Diane M. Citron, and David W. Hecht -- Clinical significance and biological basis of HIV drug resistance / Jorge L. Martinez-Cajas, Marco Petrella, and Mark A. Wainberg -- Resistance of herpesviruses to antiviral agents / G. Boivin and W.L. Drew -- Hepatitis virus resistance / Jean-Michel Pawlotsky -- Resistance to antifungal agents / Beth A. Arthington-Skaggs and John H. Rex -- An anti-mutant approach for antimicrobial use / Karl Drlica ... [et al.]
- Community-associated methicillin resistant staphylococcus aureus / Miller, L.G. -- Infections with organisms producing extended-spectrum [beta]-lactamase / Paterson, D.L., Doi, Y. -- Fluoroquinolone resistance : challenges for disease control / Parry, C.M. -- Antibiotic resistance and community-acquired pneumonia during an influenza pandemic / Moore, M.R., Whitney, C.G. -- Promoting appropriate antimicrobial drug use in the outpatient setting : what works? / Belongia, E.A., Mangione-Smith, R., Knobloch, M.J. -- Reducing antimicrobial-resistant infections in health care settings : what works? / Rezai, K., Weinstein, R.A. -- Cost of antimicrobial resistance in healthcare settings : a critical review / Merz, L.R., Guth, R.M., Fraser, V.J. -- Mass treatment of parasitic disease : implications for the development and spread of anthelmintic resistance / Curcher, T.S. ... [et al.] -- Antifungal drug resistance : clinical importance, in vitro detection and implications for prophylaxis and treatment / Arthington-Skaggs, B.A., Frade, J.P. -- Preparing for HIV drug resistance in the developing world / Bennett, D.E.
- Antimicrobial resistance in developing countries 2010SpringerGeneral issues in antimicrobial resistance -- Global perspectives of antibiotic resistance -- Mechanisms of antimicrobial resistance -- Poverty and root causes of resistance in developing countries -- What the future holds for resistance in developing countries -- Introduction of antimicrobial agents in resource-constrained countries: impact on the emergence of resistance -- Human impact of resistance -- Human immunodeficiency virus: resistance to antiretroviral drugs in developing countries -- Drug resistance in malaria in developing countries -- Drug resistance in Mycobacterium tuberculosis -- Antifungal drug resistance in developing countries -- Drug resistance in African trypanosomiasis -- Antimicrobial resistance in enteric pathogens in developing countries -- Bacterial-resistant infections in resource-limited countries -- Prevalence of resistant enterococci in developing countries -- Antimicrobial resistance in gram-negative bacteria from developing countries -- Resistance in reservoirs and human commensals -- Antimicrobial use and misuse -- Determinants of antimicrobial use: poorly understood-poorly researched -- Antimicrobial use and resistance in Africa -- Antimicrobial drug resistance in Asia -- Antimicrobial drug resistance in Latin American and the Caribbean -- Hospital infections by antimicrobial-resistant organisms in developing countries -- Cost, policy, and regulation of antimicrobials -- Economic burden of antimicrobial resistance in the developing world -- Strengthening health systems to improve access to antimicrobials and the containment of resistance -- Role of unregulated sale and dispensing of antimicrobial agents on the development of antimicrobial resistance in developing countries -- Counterfeit and substandard anti-infectives in developing countries -- Strategies to contain antimicrobial resistance -- Containment of antimicrobial resistance in developing countries and lessons learned -- Surveillance of antibiotic resistance in developing countries: needs, constraints and realities -- Vaccines: a cost-effective strategy to contain antimicrobial resistance -- Teaching appropriate antibiotic use in developing countries -- Containing global antibiotic resistance: ethical drug promotion in the developing world -- News media reporting of antimicrobial resistance in Latin America and India.
- Reports on the emergence and prevalence of resistant bacterial infections in hospitals and communities raise concerns that we may soon no longer be able to rely on antibiotics as a way to control infectious diseases. Effective medical care would require the constant introduction of novel antibiotics to keep up in the "arms race" with resistant pathogens. This book closely examines the latest developments in the field of antibacterial research and development. It starts with an overview of the growing prevalence of resistant Gram-positive and Gram-negative pathogens, including their various resistance mechanisms, prevalence, risk factors and therapeutic options. The focus then shifts to a comprehensive description of all major chemical classes with antibacterial properties, their chemistry, mode of action, and the generation of analogs; information that provides the basis for the design of improved molecules to defeat microbial infections and combat the emerging resistances. In closing, recently developed compounds already in clinical use, those in preclinical or first clinical studies, and a number of promising targets to be exploited in the discovery stage are discussed.
- Avian influenza 2008KargerEpidemiology of avian influenza / Osterhaus, A.D.M.E., Munster, V.J., Fouchier, R.A.M. -- H5N1 in Asia / Yen, H.-L. ... [et al.] -- Epidemiology and control of H5N1 avian influenza in China / Chen, H., Bu, Z., Wang, J. -- Avian influenza in Northern Eurasia / Lvov, D.K., Kaverin, N.V. -- Avian influenza in Italy, 1997-2006 / Capua, I. ... [et al.] -- Avian influenza outbreaks in Germany : development of new avian vaccines / Werner, O. ... [et al.] -- The role of pigs in interspecies transmission / Brown, I.H. -- History of research on avian influenza / Scholtissek, C. -- Reverse genetics of influenza viruses : applications in research and vaccine design / Neumann, G., Horimoto, T., Kawaoka, Y. -- Receptor specificity of influenza viruses and its alteration during interspecies transmission / Matrosovich, M.N., Gambaryan, A.S., Klenk, H.-K. -- Cleavage activation of the influenza virus hemagglutinin and its role in pathogenesis / Garten, W., Klenk, H.-D. -- Structure and function of the influenza A virus ribonucleoprotein : transcription and replication / Ortín, J. -- Influenza A virus polymerase : a determinant of host range and pathogenicity / Stech, J. -- Influenza A virus virulence and innate immunity : recent insights from new mouse models / Haller, O., Kochs, G., Staeheli, P. -- Signaling to life and death : influenza viruses and intracellular signal transduction cascades / Ludwig, S. ... [et al.] -- Cytokines in the pathogenesis of highly virulent influenza viruses in humans / Van Reeth, K. -- Antivirals and resistance / Hay, A.J., Collins, P.J., Russell, R.J. -- The 1918 influenza pandemic : lessons from the past raise questions for the future / Steel, J., Palese, P.
- Bacterial genomes and infectious diseases 2006SpringerMicrobial genomes / Voon Loong Chan -- Evolution and origin of virulence isolates / Voon Loong Chan, Philip M. Sherman, and Billy Bourke -- Genomic approach to understanding of infectious disease mechanisms / Voon Loong Chan, Philip M. Sherman, and Billy Bourke -- Knockout and disease models in toll-like receptor-mediated immunity / Huey-Lan Huang and Wen-Chen Yeh -- Campylobacter from glycome to pathogenesis / John Kelly ... [et al.] -- Genomics of helicobacter species / Zhongming Ge and David B. Schauer -- The organization of leptospira at a genomic level / Dieter M. Bulach ... [et al.] -- Listeria monocytogenes / Keith Ireton -- Mycobacterial genomes / David C. Alexander and Jun Liu -- Mycoplasma / Yuko Sasaki -- Genome comparisons of diverse staphylococcus aureus strains / Martin J. McGavin -- Type III secretion, systems in yersinia pestis, and yersinia pseudotuberculosis / James B. Bliska, Michelle B. Ryndak, and Jens P. Grabenstein -- Genomics and the evolution of pathogenic vibrio cholerae / William S. Jermyn ... [et al.] -- Future directions of infectious disease research / Philip M. Sherman, Billy Bourke, and Voon Loong Chan -- Index.
- Epidemiological concepts / Alfred S. Evans -- Public health surveillance / Philip S. Brachman -- Molecular epidemiology / Lee W. Riley -- Epidemiology of bacterial resistance to antimicrobial agents / Fred C. Tenover and John E. McGowan, Jr. -- Anthrax / Philip S. Brachman and Arnold F. Kaufmann -- Bacterial foodborne disease / Heather Green ... [et al.] -- Botulism / Patricia A. Yu ... [et al.] -- Brucellosis / Edward J. Young -- Campylobacter infections / Ban Mishu Allos -- Chancroid / Jaffar A. Al-Tawfiq -- Chlamydial infections / Julius Schachter and E. Russell Alexander -- Cholera / Manoj P. Menon, Eric D. Mintz, and Robert V. Tauxe -- Clostridium difficile / Dale N. Gerding and Stuart Johnson -- Dipththeria / Melinda Wharton -- Escherichia coli diarrhea / Herbert L. DuPont, M. Teresa Estrada-Garcia, and Zhi-Dong Jiang -- Gonococcal infections / Jonathan M. Zenilman and J. McLeod Griffiss -- Haemophilus influenzae / Janet R. Gilsdorf -- Helicobacter pylori / Sharon Perry, Catherine de Martel, and Julie Parsonnet -- Legionellosis / Roopal Patel, Matthew R. Moore, and barry S. Fields -- Leprosy / Richard I. Frankel and David M. Scollard -- Leptospirosis / Paul N. Levett and Charles N. Edwards -- Listeria monocytogenes infections / Donald Armstrong and Donald B. Louria -- Lyme disease / Roger P. Clark and Linden T. Hu -- Meningococcal infections / Robert S. Baltimore -- Mycoplasma pneumoniae and other human mycoplasmas / Deborah F. Talkington and Ken B. Waites -- Healthcare-acquired bacterial infections / Ebbing Lautenbach and Elias Abrutyn -- Pertussis / Scott A. Halperin and Gaston De Serres -- Plague / David T. Dennis and J. Erin Staples -- Pneumococcal infections / Keith P. Klugman and Charles Feldman -- Q fever / Thomas J. Marrie -- Rocky mountain spotted fever / Aaron Milstone and J. Stephen Dumler -- Salmonellosis : nontyphoidal / Michael F. Lynch and Robert V. Tauxe -- Shigellosis / Gerald T. Keusch -- Evans' infections of humans: staphylococcal infections / Zeina A. Kanafani and Vance G. Fowler, Jr. -- Streptococcal infections / Barry M. Gray and Dennis L. Stevens -- Syphilis / Anne Rompalo and Willard Cates -- Nonvenereal treponematoses / Ammar M. Ahmed ... [et al.] -- Tetanus / Steven G.F. Wassilak and Katrina Kretsinger -- Toxic shock syndrome (staphylococcal) / Arthur L. Reingold -- Tuberculosis / Diana S. Pope, Richard E. Chaisson, and George W. Comstock -- Nontuberculous mycobacterial infections / Charles L. Daley -- Tularemia / Paul S. Mead and Jeannine M. Petersen -- Typhoid fever / Myron M. Levine -- Yersinia enterocolitica infections / Ann M. Schmitz and Robert V. Tauxe.
- Section I General Considerations of Hospital Infections -- 1. Epidemiology of Healthcare-Associated Infections / Belinda Ostrowsky -- 2. The Healthcare Epidemiologist / Bryan P. Simmons -- 3. Hand Hygiene / Didier Pittet -- 4. Occupational Health Services / Elizabeth A. Bolyard -- 5. The Development of Infection Surveillance and Prevention Programs / Keith F. Woeltje -- 6. Surveillance of Healthcare-Associated Infections / Robert P. Gaynes -- 7. The Use of Prevalence Surveys for Healthcare-Associated Infections Surveillance / Bruno P. Coignard -- 8. Investigating Endemic and Epidemic Healthcare-Associated Infections / William R. Jarvis -- 9. Epidemiologic Methods for Investigating Infections in the Healthcare Setting / Ebbing Lautenbach -- 10. Use of Computerized Systems in Healthcare Epidemiology / Keith F. Woeltje -- 11. The Role of the Laboratory in Prevention of Healthcare-Associated Infections / Daniel J. Diekema -- 12. The Practice of Epidemiology in Community Hospitals / August J. Valenti -- 13. The Role of Professional, Governmental, and Regulatory Organizations in Infection Prevention and Control / Tammy S. Lundstrom -- 14. Antimicrobial Stewardship: Programmatic Efforts to Optimize Antimicrobial Use / William R. Jarvis -- 15. Multidrug-Resistant Organisms: Epidemiology and Control / Mary K. Hayden -- 16. Molecular Biology of Resistance: A Brief History of Resistance Mechanisms and the Discovery of Gene Transfer / Robert A. Bonomo -- 17. Economic Evaluation of Healthcare-Associated Infections and Infection-Control and Antimicrobial-Stewardship Interventions / Sara E. Cosgrove -- 18. Epidemiology and Control of Healthcare-Acquired Infections in Limited-Resource Settings / Victor D. Rosenthal -- Section II Functional Areas of Concern -- 19. The Inanimate Environment / John M. Boyce -- 20. Disinfection and Sterilization in Healthcare Facilities / David J. Weber -- 21. Foodborne Disease Prevention in Healthcare Facilities / Susan Springthorpe -- 22. Clinical Laboratory---Acquired Infections / L. Barth Reller -- 23. Dialysis-Associated Complications and Their Control / Priti R. Patel -- 24. The Intensive Care Unit, Part A: HAI Epidemiology, Risk Factors, Surveillance, Engineering and Administrative Infection Control Practices, and Impact / Stephan A. Harbarth -- 25. The Intensive Care Unit, Part B: Antibiotic Resistance and Prevention of CVC-BSIs, Catheter-Associated Urinary Tract Infections, and C. difficile / Dennis G. Maki -- 26. The Newborn Nursery and the Neonatal Intensive Care Unit / Nalini Singh -- 27. The Perioperative Suite / Sharon Giarrizzo-Wilson -- 28. Ambulatory Care Settings / Kathleen H. Petersen -- 29. Infections in Long-Term Care Facilities / Chesley L. Richards Jr. -- Section III Endemic and Epidemic Hospital Infections -- 30. Incidence and Nature of Endemic and Epidemic Healthcare-Associated Infections / William R. Jarvis -- 31. Urinary Tract Infections / Carol E. Chenoweth -- 32. Hospital-Acquired and Ventilator-Associated Pneumonia / Henri Balaguera -- 33. Nosocomial Tuberculosis / Faiz Ahmad Khan -- 34. Infectious Gastroenteritis / Benjamin A. Lopman -- 35. Central Nervous System Infections / W. Michael Scheld -- 36. Surgical Site Infections / Keith S. Kaye -- 37. Infections of Burn Wounds / Basil A. Pruitt, Jr. -- 38. Infections due to Infusion Therapy / Leonard A. Mermel -- 39. Infections of Implantable Cardiac and Vascular Devices / Raymond Y. Chinn -- 40. Infections in Skeletal Prosthesis and Allografts / Daniel P. Lew -- 41. The Importance of Infection Control in Controlling Antimicrobial-Resistant Organisms / Barry M. Farr -- 42. Healthcare-Associated Respiratory Viral Infections / Janice Lo -- 43. Preventing Transmission of Bloodborne Pathogens in the Healthcare Setting / David K. Henderson -- 44. Healthcare-Associated Fungal Infections / Benjamin J. Park -- 45. Healthcare-Associated Infections in Transplant Recipients / Kent Sepkowitz -- 46. Miscellaneous Procedure-Related Infections / Robert A. Weinstein -- 47. Public Reporting of Healthcare-Associated Infection Rates / Michael P. Stevens -- 48. Patient Safety / Moi Lin Ling.
- Biodefense research methodology and animal models 2006CRCnetBASE
- The aim of this book is to provide readers with a wide overview of the main healthcare-associated infections caused by bacteria and fungi able to grow as biofilm. The recently acquired knowledge on the pivotal role played by biofilm-growing microorganisms in healthcare-related infections has given a new dynamic to detection, prevention and treatment of these infections in patients admitted to both acute care hospitals and long-term care facilities. Clinicians, hygienists and microbiologists will be updated by leading scientists on the state-of-art of biofilm-based infections and on the most innovative strategies for prevention and treatment of these infections, often caused by emerging multidrug-resistant biofilm-growing microorganisms.
- The aim of this book is to provide readers with a wide overview of the main healthcare-associated infections caused by bacteria and fungi able to grow as biofilm. The recently acquired knowledge on the pivotal role played by biofilm-growing microorganisms in healthcare-related infections has given a new dynamic to detection, prevention and treatment of these infections in patients admitted to both acute care hospitals and long-term care facilities. Clinicians, hygienists and microbiologists will be updated by leading scientists on the state-of-art of biofilm-based infections and on the most innovative strategies for prevention and treatment of these infections, often caused by emerging multidrug-resistant biofilm-growing microorganisms.
- Biofilms, infection, and antimicrobial therapy 2006CRCnetBASEMicrobial biofilms / Xiuping Jiang and John L. Pace -- Economic impact of biofilms on treatment costs / John G. Thomas, Isaiah Litton, and Harald Rinde -- Biofilm-related indwelling medical device infections / Matthew K. Schinabeck and Mahmoud A. Ghannoum -- Medical device composition and biological secretion influences on biofilm formation / Sean P. Gorman and David S. Jones -- Role of biofilms in infections caused by Escherichia coli / Grégory Jubelin, Corinne Dorel, and Philippe Lejeune -- Staphylococcus aureus biofilms / Julie M. Higashi and Paul M. Sullam -- Coagulase-negative staphylococci / Dietrich Mach ... [et al.] -- Pseudomonas aeruginosa biofilm infections in cystic fibrosis / Andrea Smiley and Daniel J. Hassett -- Candida / Stephen Hawser and Khalid Islam -- Current perspectives on the regulation of the ica operon and biofilm formation in Staphylococcus epidermidis / Paul D. Fey and Luke D. Handke -- Cell-to-cell communication in bacteria / Kenneth D. Tucker and Luciano Passador -- Persisters: specialized cells responsible for biofilm tolerance to antimicrobial agents / Kim Lewis ... [et al.] -- Minimal biofilm eradication concentration (MBEC) assay: susceptibility testing for biofilms / Howard Ceri ... [et al.] -- Environmental cues regulate virulence and biofilm formation / John L. Pace and Steven M. Frey -- In vivo models for the study of biomaterial-associated infection by biofilm-forming staphylococci / Luke D. Handke and Mark E. Rupp -- Host response to biofilms / Susan Meier-Davis -- Pharmacodynamics and the treatment of IMD-related infections / Roger Finch and Sarah Gander -- Protein synthesis inhibitors, fluoroquinolones, and rifampin for biofilm infections / Steven L. Barriere -- [beta][beta]-lactams for the treatment of biofilm-associated infections / Ingrid L. Dodge, Karen Joy Shaw, and Karen Bush -- Glycopeptide antibacterials and the treatment of biofilm-related infections / John L. Pace, Roasaire Verna, and Jan Verhoef -- Antibiotic resistance in biofilms / Nafsika H. Georgopapadakou -- Treatment protocols for infections of vascular catheters / Russell E. Lewis and Issam I Raad -- Treatment protocols for bacterial endocarditis and infection of electrophysiologic cardiac devices / Martin E. Stryjewski and G. Ralph Corey -- Treatment protocol of infections of orthopedic devices / Vera Antonios, Elie Berbari, and Douglas Osmon.
- Department of defense capabilities supporting bioterrorism response -- Modeling for bioterrorism incidents -- Biological weapons defense: effect levels -- Pathogenesis by aerosol -- Bacillus anthracis and the pathogenesis of anthrax -- Virologic and pathogenic aspects of the variola virus (Smallpox) as a bioweapon -- Plague vaccines: retrospective analysis and future developments -- Medical protection against brucellosis -- Pathogenesis of and immunity to coxiella burnetii -- Glanders: new insights into an old disease -- Medical countermeasures for filoviruses and other viral agents -- Medical defense against protein toxin weapons: review and perspective -- Antimicrobials for biological warfare agents -- Nonspecific immunomodulator therapy: CpG -- Decontamination -- Definition and overview of emerging threats -- Department of defense global emerging infections system programs in biodefense -- Information resources and database development for defense against biological weapons -- Genomic efforts with biodefense pathogens -- Genomics for biodefense: exploiting the francisella tularensis genome sequence -- Genetic fingerprinting of biodefense pathogens for epidemiology and forensic investigation -- Yersinia pestis as an emerged pathogen: what lessons can be learned? -- Requirements for biological threat identification systems -- DNA-based diagnostic tests for detection and identification of biological weapons -- Concepts for the development of immunodiagnostic assays for detection and diagnosis of biothreat agents.
- Anthrax : a disease and a weapon / Kenneth Alibek, Catherine Lobanova and Serguei Popov -- Plague as a biological weapon / David T. Dennis -- Tularemia and bioterrorism / Lisa Hodges and Robert L. Penn -- Melioidosis and Glanders as possible biological weapons / David Allan Brett Dance -- Smallpox as a weapon for bioterrorism / J. Michael Lane -- Hemorrhagic Fever viruses as biological weapons / Allison Groseth ... [et al.] -- Botulism as a potential agent of bioterrorism / Thomas P. Bleck -- Ricin : a possible, noninfectious biological weapon / Maor Maman and Yoav Yehezkelli -- Bioterrorism alert for health care workers / Theodore J. Cieslak, George W. Christopher and Edward M. Eitzen -- The economics of planning and preparing for bioterrorism / Martin I. Meltzer.
- Birkhäuser Advances in infectious diseases 2005-SpringerInfectious diseases remain a substantial drain on human well-being and economies despite the availability of modern drugs. New pathogens emerge and known pathogens change their geographical distribution and their susceptibility to the available drugs. An understanding of the structure and function of infectious disease pathogens is a major scientific challenge with important potential applications. This monograph series provides up-to-date information on the latest developments in infectious disease research. The multi-authored volumes cover basic biology and biochemistry of pathogens as well as applied medical aspects and implications for public health and policy.-- Excerpted from publisher notes.
- Brain immune system signal molecules in protection from aerobic and anaerobic infections 2012SpringerThe Cytokine System -- The Discovery of the Brain Immunomodulators -- Brain Neuroendocrine Immune System: Neurosecretion of Interleukins and New Cytokines Produced by NSO and NPV of Hypothalamus -- Antibacterial and Antiviral Activity of PRP-1 (Galarmin) and Some Immunological Mechanisms of its Action -- Treatment and Prophylaxis of Anthrax by Galarmin: Receptor Tyrosine Kinases is a Target of Galarmin -- Prophylaxis and Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection with Proline-Rich Polypeptides Galarmin and Its Structural Analogues in an Experimental Murine Model -- Treatment of Clostridium Perfringens-induced Gas Gangrene by New Cytokines of Brain -- Hypothalamic, Proline-Rich Polypeptide (Galarmin) has Protective and Immunogenic Activity on Experimental Mycobacterium Tuberculosis Infection -- Brain-Bone Marrow Neurohumoral Axis: Galarmin Controls Differentiation, Proliferation and Mobilization of Bone Marrow Progenitor cells -- Antioxidant-Antiradical and Electron Donating Function of Galarmin and Gx-NH2 -- Discussion -- Summary.
- Executive summary -- Report of the working-group meeting / Christos Louis and Bart G.J. Knols -- Review of previous applications of genetics to vector control / Chris F. Curtis -- Genomics and expected benefits for vector entomology / Christos Louis -- Genetic approaches for malaria control / Marcelo Jacobs-Lorena -- Current thoughts about the integration of field and laboratory sciences in genetic control of disease vectors / Thomas W. Scott -- Genetic approaches in Aedes aegypti for control of dengue: an overview / Kenneth Olson .... [et al.] -- Malaria and dengue vector biology and control in West and Central Africa / Didier Fontenille and Pierre Carnevale -- Malaria and dengue vector biology and control in Southern and Eastern Africa / Maureen Coetzee -- Malaria and dengue vector biology and control in Southeast Asia / Pattamaporn Kittayapong -- Malaria and dengue vector biology and control in Latin America / Mario H. Rodriguez -- Transition from the laboratory to the field and effective interplay / Christos Louis -- Evaluation of drive mechanisms (including transgenes and drivers) in different environmental conditions and genetic backgrounds / Anthony A. James ... [et al.] -- Tools for monitoring the genetic structure and stability of mosquito populations / Gregory C. Lanzaro, Sergey Nuzhdin and Frederic Tripet -- What are relevant assays for refractoriness / George K. Christophides ... [et al.] -- Fitness studies: developing a consensus methodology / Thomas W. Scott ... [et al.] -- Mosquito mating behaviour / Willem Takken ... [et al.] -- Pathogen evolution issues in genetically modified mosquito vector strategies / Mario H. Rodriquez -- Models to investigate some issues regarding the feasibility of driving refractoriness genes into mosquito vector populations / Chris F. Curtis -- Identification and characterization of field sites for genetic control of disease vectors / Bart G.J. Knols and Hervé Bossin -- Application of genetically modified mosquitoes in national vector control programmes: thoughts on integrated control / Abraham Mnzava ... [et al.] -- Entomological correlates of epidemiological impacts: how do we know it is working? / Andrew Githeko -- Ethical, legal and social issues in the use of genetically modified vectors for disease control / Yeya T. Touré and Lucien Manga.
- Canine and feline infectious diseases 2014ScienceDirectBasic principles in the diagnosis and management of small animal infection -- Laboratory diagnosis of canine and feline infectious diseases -- Isolation in cell culture -- Immunoassays -- Isolation and identification of aerobic and anaerobic bacteria -- Isolation and identification of fungi -- Nucleic acid detection assays -- Antiinfective therapy -- Principles of antiinfective therapy -- Antiviral and immunomodulatory drugs -- Antibacterial drugs -- Antifungal drugs -- Antiprotozoal drugs -- Basic principles for infection control -- Infection control programs for dogs and cats -- Immunization -- Major infectious diseases and their etiologic agents -- Viral diseases -- Rabies -- Canine parvovirus infections and other viral enteritides -- Canine distemper virus infection -- Canine herpesvirus infection -- Canine viral respiratory infections -- Infectious canine hepatitis -- Feline panleukopenia virus infection and other viral enteritides -- Feline coronavirus infection -- Feline immunodeficiency virus infection -- Feline leukemia virus infection -- Feline respiratory viral infections -- Feline poxvirus infections -- Pseudorabies -- Viral papillomatosis -- Vector-borne and other viral encephalitides -- Bacterial diseases -- Ehrlichiosis -- Anaplasmosis -- Rocky mountain spotted fever -- Salmon poisoning disease -- Coxiellosis and q fever -- Chlamydial infections -- Streptococcal and enterococcal infections -- Staphylococcus infections -- Gram-negative bacterial infections -- Anaerobic bacterial infections -- Bordetellosis -- Cell wall-deficient bacterial infections -- Mycoplasma infections -- Hemoplasma infections -- Actinomycosis -- Nocardiosis -- Mycobacterial infections -- Salmonellosis -- Enteric Escherichia coli infections -- Campylobacteriosis -- Enteric clostridial infections -- Gastric Helicobacter-like infections -- Leptospirosis -- Lyme borreliosis -- Bartonellosis -- Canine brucellosis -- Tetanus and botulism -- Yersinia pestis (plague) and other yersinioses -- Tularemia -- Bite and scratch wound infections -- Fungal and algal diseases -- Dermatophytosis -- Malassezia infections -- Blastomycosis -- Histoplasmosis -- Cryptococcosis -- Coccidioidomycosis -- Sporotrichosis -- Aspergillosis -- Rhinosporidiosis -- Candidiasis -- Miscellaneous fungal diseases -- Pythiosis, lagenidiosis, and zygomycosis -- Protothecosis -- Pneumocystosis -- Protozoal diseases -- Toxoplasmosis -- Neosporosis -- Leishmaniosis -- Babesiosis -- Cytauxzoonosis -- Canine and feline hepatozoonosis -- Trypanosomiasis -- Giardiasis -- Trichomoniasis -- Cryptosporidiosis -- Isosporiasis -- Miscellaneous protozoal diseases -- Infections of selected organ systems -- Pyoderma, otitis externa, and otitis media -- Osteomyelitis, discospondylitis, and infectious arthritis -- Infections of the cardiovascular system -- Bacterial bronchopneumonia and pyothorax -- Intra-abdominal infections -- Bacterial infections of the genitourinary tract -- Bacterial meningitis -- Vaccination schedules for dogs and cats.
- Challenges in infectious diseases 2013Springer"This new volume ... aims to address demands and challenges that various infections present to the world at large ('global challenges'), such as the HIV pandemic, continuous threat of spreading common multiresistant pathogenic bacteria, multidrug and extensive drug-resistant tuberculosis, and the influence we can expect on these epidemics with global climate change and international urbanization ... Chapters on these various topics authored by world-renowned experts on these areas provide state-of-the-art reviews on epidemiology, biology, clinical aspects, prevention, current approaches to control, and prevention such as new vaccines, and reassessment of past and present methods are discussed"--Preface.
- Epidemiology and prevention and control programs for chlamydia / C.L. Satterwhite, J.M. Douglas, Jr. -- Chlamydia trachomatis pathogenicity and disease / D. Dean -- Chlamydia trachomatis genome structure / T.E. Putman, D.D. Rockey -- Chlamydia trachomatis : molecular testing methods / C.A. Gaydos -- Treatment of chlamydia trachomatis infections / M.R. Hammerschlag -- The Immunologic Response to Urogenital Infection / R.M. Johnson, W. Geisler -- Chlamydia vaccine development / J.U. Igietseme, C.M. Black -- Maternal and infant chlamydia trachomatis infections / I.G.I.J.G. Rours, M.R. Hammerschlag -- Chlamydia trachomatis infection among sexual minorities / D. Singh, J.M. Marrazzo -- Lymphogranuloma venereum : a concise outline of an emerging infection among men who have sex with men / H.J.C. de Vries, S. Morré.
- Cholera outbreaks 2014SpringerThe most feared attribute of the human pathogen Vibrio cholerae is its ability to cause outbreaks that spread like wildfire, completely overwhelming public health systems and causing widespread suffering and death. This volume starts with a description of the contrasting patterns of outbreaks caused by the classical and El Tor biotypes of V. cholerae. Subsequent chapters examine cholera outbreaks in detail, including possible sources of infection and molecular epidemiology on three different continents, the emergence of new clones through the bactericidal selection process of lytic cholera phages, the circulation and transmission of clones of the pathogen during outbreaks, and novel approaches to modeling cholera outbreaks. A further contribution deals with the application of the genomic sciences to trace the spread of cholera epidemics and how this information can be used to control cholera outbreaks. The book closes with an analysis of the potential use of killed oral cholera vaccines to stop the spread of cholera outbreaks.
- This clinical case book serves as a useful guide for dermatologists, internists, family practitioners, pediatricians, and anyone else charged with the care of infectious diseases of the skin of parasitic, fungal, bacterial, and viral origin. The case-based format distinguishes this work from a reference-style textbook, allowing readers to relate the presented cases to their own practice. Clinical Cases in Infections and Infestations of the Skin provides help and insight for clinicians in managing skin disease, with each chapter serving as a springboard for further pursuit and more extensive training. ℗ℓThe reader will find useful information and tools to help patients and will enable readers to add to their current clinical regimens by becoming familiar with healing systems beyond medical dermatology. The book will enable those new to the field to develop a literacy and competence in the management of infectious dermatology.℗ℓ For the more experienced learner, it will assist in finding new ways to sharpen diagnostic and treatment acumens.
- Primary immunodeficiency diseases (PIDs) are a heterogeneous group of inherited disorders characterized by different defects in the development and function of the immune system. These defects render patients susceptible to a variety of infectious diseases. Knowledge of normal immunity and specific warning signs and symptoms can help physicians to identify those children with underlying PIDs.This book aims to increase the clinical awareness and knowledge of practicing clinicians regarding the diagnosis and management of PIDs. In order to achieve this goal, about 90 cases drawn from real life are presented, along with approximately 300 related questions. The selected case reports are the result of the invaluable cooperation of more than 40 scientists in the field of immunodeficiency. They focus both on the presenting features of patients with PIDs and on the required further investigation and management. Although the case scenarios relate to real histories, some modifications have been made for educational purposes. Each of the numbered cases is followed by the questions, their answers, and additional discussion. Each question focuses on a particular aspect of the PID under consideration, and the topics covered include clinical diagnosis, laboratory findings, molecular mechanisms, and therapy.This practical, case-oriented book will be an invaluable source of guidance on the diagnosis and treatment of patients with PIDs and will be relevant for those working in a variety of specialties and subspecialties.
- Microbes -- Microbial attack and control by intrinsic defences -- Specific pathogens. Bacteria ; Fungi ; Arthropods ; Parasites ; Viruses -- Microbial attack succeeds : clinical infection -- Microbe control by extrinsic defences.
- Clinical use of anti-infective agents a guide on how to prescribe drugs used to treat infections 2012Springer
- Clostridium difficile new challenges for an old foe 2013Future MedClostridium difficile : new challenges for an old foe / Glenn S. Tillotson & Karl Weiss -- Clostridium difficile infection : a global threat / Nuttanun Suramaethakul & Teena Chopra -- Pathogenicity mechanisms of Clostridium difficile / Mark M. Collery, Revathi Govind, Nigel P. Minton & Sarah A. Kuehne -- Immunology and Clostridium difficile / Ciarán P. Kelly & Saurabh Sethi -- The microbiome and Clostridium difficile infection / Charles Y. Chiu & Dylan R. Pillai -- Economic burden of Clostridium difficile infection / Samuel L. Aitken, Dhara N. Shah & Kevin W. Garey -- Laboratory diagnosis of Clostridium difficile infection / Peter H. Gilligan -- Conventional therapeutics for Clostridium difficile infection / Jessica Martin & Mark Wilcox -- Infection control issues in Clostridium difficile / Scott Curry -- Future and alternative approaches to managing Clostridium difficile infection / Glenn S. Tillotson & Karl Weiss -- Recent advances with Clostridium difficile / Joni Tillotson & Glenn S. Tillotson -- Index.
- CNS infections a clinical approach 2014Springer"This clinically oriented book covers selected infections of the central nervous system which are of considerable current interest. Aspects that are less well documented, such as spinal cord infections, central nervous system infections in patients with cancer, tropical infections, healthcare-associated ventriculitis or meningitis, and immunological problems in the international traveler are also discussed, as these are all problems relevant to daily practice."--Publisher's website.
- Color atlas of infective endocarditis 2006Springer
- Common cold 2009Springer
- Community-acquired pneumonia 2007SpringerDiagnosis and treatment of community acquired pneumonia - the German perspective -- Detection of respiratory bacterial pathogens -- Viral pathogens and epidemiology, detection, therapy and resistance -- Resistance in Streptococcus pneumoniae -- Influenza -- Pathogenesis of Chlamydophila pneumoniae infections - epidemiology, immunity, cell biology, virulence factors -- Legionnaires' disease and its agent Legionella pneumophila -- Pathogenesis of Streptococcus pneumoniae infections: adaptive immunity, innate immunity, cell biology, virulence factors -- Pathogenesis of Mycoplasma pneumoniae infections: adaptive immunity, innate immunity, cell biology, and virulence factors -- Community-acquired pneumonia: paving the way towards new vaccination concepts.
- Comparative hepatitis 2008Springer
- Congenital cytomegalovirus (CMV) infection is the most common intrauterine transmitted viral infection, with a tremendous impact on fetuses and newborns. In this book the history of this disease, its pathophysiological background, epidemiology and symptoms, as well as diagnostic and therapeutic strategies, will be discussed. Since economic aspects are gaining more and more importance in health politics, one chapter is dedicated to this issue in the context of congenital CMV infection. The content is based on the latest scientific findings and written in an understandable manner, allowing persons not working in the field of congenital CMV to also profit from it. Thus, this book is of interest for medical doctors, nurses, midwives, economists, but also for men and women who want to inform themselves about this topic.
- Considerations for viral disease eradication lessons learned and future strategies : workshop summary 2002NAP
- Cryptosporidium and cryptosporidiosis. 2nd ed. 2008CRCnetBASEGeneral biology / Ronald Fayer -- Genomics / Jessica C. Kissinger -- Biochemistry / Guan Zhu -- Epidemiology / Gordon Nichols -- Molecular epidemiology / Lihua Xiao and Una M. Ryan -- Diagnostics / Huw Smith -- Immune responses / Vincent McDonald -- Clinical disease and pathology / Cirle Alcantara Warren and -- Richard l. Guerrant -- Prophylaxis and chemotherapy / Heather D. Stockdale, Jennifer A. Spencer, and Byron L. Blagburn -- Foodborne transmission / Ynes R. Ortega and Vitaliano A. Cama -- Waterborne: drinking water / Jennifer L. Clancy and Thomas M. Hargy -- Waterborne: recreational water / Michael Beach -- Waste management / Dwight D. Bowman -- Fish, amphibians and reptiles / Thaddeus Graczyk -- Birds / Una Ryan and Lihua Xiao -- Zoo and wild mammals / Olga Matos -- Companion animals / Mónica Santín and James M. Trout -- Livestock / Mónica Santín and James M. Trout -- Animal models / Saul Tzipori and Giovanni Widmer -- In vitro cultivation / Michael J. Arrowood.
- Cryptosporidium parasite and disease 2014SpringerThis new volume on Cryptosporidium and Cryptosporidiosis discusses all relevant aspects of the biology, molecular biology, host-parasite interaction, epidemiology as well as diagnosis and treatment of these widespread parasites. It represents a useful guide for physicians, microbiologists, veterinarians and water professionals seeking advanced knowledge and guidance about these important parasitic pathogens. A section on practical lab procedures discusses step-by-step guidelines for sample preparation and lab procedures. The new book may further serve as a reference work for graduate students in medical and veterinary microbiology.
- A concise guide to TB control / Stefan HE Kaufmann -- Unmet medical needs for diagnostics, drugs and vaccines / Syed Huq & Peter D.O. Davies -- TB diagnostics : current pipeline, new developments and unmet needs / Madhukar Pai, Samuel G. Schumacher, Hojoon Sohn & Claudia M. Denkinger -- Antituberculosis therapy and current global guidelines / Giovanni Battista Migliori, Giovanni Sotgiu, Rosella Centis, Malgorzata Grzemska, Dennis Falzon, Haileyesus Getahun & Mario C. Raviglione -- New therapeutics in development and future directions / Anna Upton & Zhenkun Ma -- New vaccines in development and future direction / Helen McShane & Rosalind Rowland.
- Features of enteric infections in Asia -- Molecular epidemiology of vibrio cholerae and campylobacters isolated in Asian countries -- Diarrheal diseases and probiotics -- Dengue and chikungunya virus infection in Southeast Asia: active governmental intervention in Republic of Singapore -- Current global situation of tuberculosis, with a focus on Japan -- Tuberculosis among the poor -- The status and trends of HIV/AIDS epidemics in Asia and the Pacific -- Disease characteristics and treatment of 2009 H1N1 influenza -- Drug-resistant respiratory pathogens in Japan.
- Subcutaneous and deep mycoses -- Hyalohyphomycosis -- Superficial mycoses -- Algae -- Mycobacteria -- Viruses -- Rickettsiae -- Crusted scabies -- Protozoa -- Helminth -- Spirochete -- Gram-Positive bacteria -- Gram-negative bacteria -- Viral related malignancies -- Clues to the diagnosis of skin lesions in the immunocompromised host -- Differential diagnoses.
- Cytopathology of infectious diseases 2012SpringerIntroduction -- Specimen Collection and Handling -- Host Reactions to Infection -- Microbiology -- Gynecological Infections -- Pulmonary Infections -- Gastrointestinal and Hepatobiliary Infections -- Urinary Tract Infections -- Central Nervous System Infections -- Hematologic Infections -- Breast, Skin, and Musculoskeletal Infections -- Head and Neck Infections -- Immunosuppressed Host -- Ancillary Investigations -- Mimics and Contaminants.
- "Since the second edition of Dengue haemorrhagic fever: diagnosis, treatment, prevention and control was published by the World Health Organization (WHO) in 1997, the magnitude of the dengue problem has increased dramatically and has extended geographically to many previously unaffected areas. It was then, and remains today, the most important arthropod-borne viral disease of humans. Activities undertaken by WHO regarding dengue are most recently guided at the global policy level by World Health Assembly resolution WHA55.17 (adopted by the Fifty-fifth World Health Assembly in 2002) and at the regional level by resolution CE140.R17 of the Pan American Sanitary Conference (2007), resolution WPR/RC59.R6 of the WHO Regional Committee for the Western Pacific (2008) and resolution SEA/RC61/R5 of the WHO Regional Committee for South-East Asia (2008). This new edition has been produced to make widely available to health practitioners, laboratory personnel, those involved in vector control and other public health officials, a concise source of information of worldwide relevance on dengue. The guidelines provide updated practical information on the clinical management and delivery of clinical services; vector management and delivery of vector control services; laboratory diagnosis and diagnostic tests; and surveillance, emergency preparedness and response. Looking ahead, some indications of new and promising avenues of research are also described. Additional and more detailed specific guidance on the various specialist areas related to dengue are available from other sources in WHO and elsewhere, some of which are cited in the references. The contributions of, and review by, many experts both within and outside WHO have facilitated the preparation of this publication through consultative and peer review processes. All contributors are gratefully acknowledged, a list of whom appears under "Acknowledgements". These guidelines are the result of collaboration between the WHO Department of Control Neglected Tropical Diseases, the WHO Department of Epidemic and Pandemic Alert and Response, and the Special Programme for Research and Training in Tropical Diseases. This publication is intended to contribute to prevention and control of the morbidity and mortality associated with dengue and to serve as an authoritative reference source for health workers and researchers. These guidelines are not intended to replace national guidelines but to assist in the development of national or regional guidelines. They are expected to remain valid for five years (until 2014), although developments in research could change their validity, since many aspects of the prevention and control of dengue are currently being investigated in a variety of studies. The guidelines contain the most up-to-date information at the time of writing. However, the results of studies are being published regularly and should be taken into account. To address this challenge, the guide is also available on the Internet and will be updated regularly by WHO." - p. v.
- Dengue-- transmission, diagnosis & surveillance 2014Future MedDengue : transmission, diagnosis and surveillance / James Whitehorn & Jeremy Farrar -- Biomarkers for dengue : prospects and challenges / Sophie Yacoub, Annette Fox, Nguyen Van Kinh, Gavin Screaton & Heiman Wertheim -- Dengue diagnosis : commercially available kits and laboratory support / Monique da Rocha Queiroz Lima, Rita Maria Ribeiro Nogueira & Flávia Barreto dos Santos -- Lessons learned from dengue : focus on Taiwan / Tzong-Shiann Ho, Chiou-Feng Lin, Ching-Chuan Liu, Trai-Ming Yeh, Robert Anderson & Yee-Shin Lin -- Dengue and international travel / Silvia Odolini, Alberto Matteelli & Francesco Castelli -- Intraepidemic increases in dengue disease severity : applying lessons on surveillance & transmission / Scott B. Halstead -- Prospects for controlling dengue spread : vaccines and vector control / Monica A. McArthur, Marcelo B. Sztein & Robert Edelman -- Ask the experts : surveillance of global dengue distribution / Jane Messina, Oliver Brady, Simon Hay, Jeremy Farrar & James Whitehorn -- Multiple choice questions : answers.
- Part One Approach to Patients -- Chapter 1 Approach to Patients with Suspected Fungal Infections -- Part Two Laboratory and Radiological Diagnosis -- Chapter 2 Basic Mycology -- Chapter 3 Diagnostic Molecular Biology -- Chapter 4 Diagnostic Histopathology -- Chapter 5 Diagnostic Immunology -- Chapter 6 Diagnostic Radiology -- Part Three Antifungal Agents -- Chapter 7 Antifungal Agents -- Part Four Mycoses -- Chapter 8 Candidiasis -- Chapter 9 Infection Due to non-Candidal Yeasts -- Chapter 10 Aspergillosis -- Chapter 11 Hyalohyphomycosis -- Infection Due to Hyaline Moulds -- Chapter 12 Phaeohyphomycosis -- Infection Due to Dark (Dematiaceous) Moulds -- Chapter 13 Mucormycosis (Zygomycosis) -- Chapter 14 Pneumocystosis -- Chapter 15 Cryptococcosis -- Chapter 16 Blastomycosis -- Chapter 17 Coccidioidomycosis -- Chapter 18 Histoplasmosis -- Chapter 19 Paracoccidioidomycosis -- Chapter 20 Sporotrichosis -- Chapter 21 Dermatophytosis (Tinea) and Other Superficial Fungal Infections -- Chapter 22 Fungal Infections of Implantation (Chromoblastomycosis, Mycetoma, Entomophthoramycosis and Lacaziosis) -- Part Five Instructive Cases. Instructive Cases -- Instructive Cases Discussion.
- Diagnostic pathology of infectious disease 2010ClinicalKey"Online and print, this comprehensive, organ-based reference is an invaluable tool for the accurate diagnosis of infectious diseases - from the common to the most challenging." "Integrates the latest techniques in immunohistochemistry and molecular genetics throughout the text for comprehensive information on all investigative contexts relevant to ensuring diagnostic accuracy; Emphasizes the host responses critical in differential diagnosis to serve as a second opinion when non-infectious diagnoses mimic and confound the diagnosis of infection; Provides a complete visual guide to suspect lesions through superb, high-quality, full-color illustrations of key aspects of various diseases that facilitate the rapid identification of biopsy specimen; Features tables that list differential diagnosis for each lesion for quick summaries of key points in problem areas; and Highlights morphological characteristics and landmarks of tissue samples throughout the text for easy access to information necessary for signing out specimens."--BOOK JACKET.
- Disease control priorities in developing countries. 2nd ed. 2006NCBI Bookshelf
- Perspectives on infection challenges and solutions / Manivannan -- Sisyphus in the microbial world revisited : global governance, antimicrobial strategies, and humanity's health / Fidler -- The need for safer and better microbiocides for infection control / Sattar, Springthorpe -- Microbiological concerns in non-sterile manufacturing / Farrington, Polarine -- New technologies in disinfection and infection control / Ramirez -- Biocides : modes of action and mechanisms of resistance / McDonnell -- A pragmatic approach to judicious selection and proper use of disinfectant and antiseptic agents in healthcare setting / Suljagic -- Extended activity of healthcare antiseptic products / Newman, Kaiser -- Disinfectant rotation in a cleaning/disinfection program for cleanrooms and controlled environments / Sutton -- Reprocessing flexible endoscopes : origin of standards, overview of structure/function, and review of recent outbreaks / Antonucci, Williams, Robinson -- Microbiological testing of disinfectants and decontaminants for critical surfaces / Klein -- Regulatory constraints on disinfectants and decontamination / Sarli -- Biofilms : a summarized account and control strategies / Nandakumar, Sreekumari -- Consequences of biofilms on indwelling medical devices : costs and prevention / Thomas, Nakaishi, Corum -- Infection-resistant implantable devices : biofilm problems and design strategies / Smith, Perera -- Infections of intracardiac devices / Yesenosky ... [et al.] -- Intrauterine devices : infections and biofilms / Pereira, Pruthi -- Antimicrobial urinary catheters / Stickler, Sabbuba -- Risk factors for post-operative infectious complications after abdominal surgery / Pessaux, Lermite.
- Drug interactions in infectious diseases. 3rd ed. 2011SpringerIntroduction to Drug-Drug Interactions -- Mechanisms of Drug Interactions I: Absorption, Metabolism, and Excretion -- Mechanisms of Drug Interactions II: Transport Proteins -- Drug-Food Interactions -- Interactions Between Herbs and Antiinfective Medications -- Drug-Cytokine Interactions -- Beta-Lactam Antibiotics -- Macrolides, Azalides, and Ketolides -- Quinolones -- Glycopeptides, Lipopeptides, and Lipoglycopeptides -- Miscellaneous Antibiotics -- Drugs for Tuberculosis -- Drug Interactions with Antiretrovirals for HIV Infection -- Non-HIV Antiviral Agents -- Antifungal Agents -- Antimalarial Agents -- Antiprotozoal and Anthelmintic Agents -- Drug Interaction Considerations Throughout Drug Development -- Probe Cocktail Studies -- Design and Data Analysis in Drug Interaction Studies.
- Dynamic modeling of diseases and pests 2009SpringerThe why and how of dynamic modeling -- Basic epidemic models -- Insect dynamics -- Malaria and sickle cell anemia -- Encephalitis -- Chagas disease -- Lyme disease -- Chicken pox and shingles -- Toxoplasmosis -- The zebra mussel -- Biological control of pestilence -- Indirect susceptible-infected-resistant models of arboviral encephalitis transmission -- Chaos and pestilence -- Catastrophe and pestilence -- Spatial pestilence dynamics.
- This book covers modeling of insect vector-borne infectious diseases, which account for some three million deaths worldwide. The authors describe processes for quantifying the vital parameters of diseases transmitted by mosquitoes, sand flies, fleas and ticks. Despite great advances in public health worldwide, insect vector-borne infectious diseases remain a leading cause of morbidity and mortality. Diseases that are transmitted by arthropods such as mosquitoes, sand flies, fleas, and ticks affect hundreds of millions of people and account for nearly three million deaths all over the world. In the past there was very little hope of controlling the epidemics caused by these diseases, but modern advancements in science and technology are providing a variety of ways in which these diseases can be handled. Clearly, the process of transmission of an infectious disease is a nonlinear dynamic process which can be understood only by appropriately quantifying the vital parameters that govern these dynamics.
- This book covers modeling of insect vector-borne infectious diseases, which account for some three million deaths worldwide. The authors describe processes for quantifying the vital parameters of diseases transmitted by mosquitoes, sand flies, fleas and ticks. Despite great advances in public health worldwide, insect vector-borne infectious diseases remain a leading cause of morbidity and mortality. Diseases that are transmitted by arthropods such as mosquitoes, sand flies, fleas, and ticks affect hundreds of millions of people and account for nearly three million deaths all over the world. In the past there was very little hope of controlling the epidemics caused by these diseases, but modern advancements in science and technology are providing a variety of ways in which these diseases can be handled. Clearly, the process of transmission of an infectious disease is a nonlinear dynamic process which can be understood only by appropriately quantifying the vital parameters that govern these dynamics --c Source other than Library of Congress.
- The Overview of Needs and Requirements covers the costs of the Ebola response and preparedness activities. The needs and requirements are based on the latest information available from each of the most affected countries. The national plans and budgets comprise the framework and the Overview of Needs and Requirements defines the contributions planed by the UN system as well as the major international civil society organizations.
- Chapter 1. Identifying general requirements -- Chapter 2. Identifying detailed requirements -- Chapter 3. Selecting a solution -- Chapter 4. Implementing an electronic recording and reporting system .
- Global effects and prevention of emerging and epidemic pathogens: cholera and citrus greening as examples -- Surveillance -- Epidemiological surveillance of highly pathogenic diseases in Kazakhstan -- Surveillance on plague in Natural foci in Georgia -- Application of modern techniques for studying bacterial pathogens in Georgia -- Especially dangerous infections in Azerbaijan -- Strengthening the early-warning function of the surveillance system: the Macedonian experience -- Integrating geographic information systems and ecological niche modeling into disease ecology: a case study of Bacillus anthracis in the United States and Mexico -- Molecular analysis and tools -- Applications of paleomicrobiology to the understanding of emerging and re-emerging infectious diseases -- Characterization of a putative hemagglutinin gene in the caprine model for brucellosis -- Pathoadaptation of especially dangerous pathogens -- Detection of pathogens via high-throughput sequencing -- Environmental infuences on the relative stability of baculoviruses and Vaccinia virus: a review.
- A global perspective on the management and prevention of emerging and re-emerging diseases Emerging infectious diseases are newly identified or otherwise previously unknown infections that cause public health challenges. Re-emerging infectious diseases are due to both the reappearance of and an increase in the number of infections from a disease that is known, but which had formerly caused so few infections that it was no longer considered a public health problem. The factors that cause the emergence or re-emergence of a disease are diverse. This book takes a look at the worl
- Emerging foodborne pathogens 2006CRCnetBASEpt. 1. Identifying emerging pathogens -- pt. 2. Individual pathogens.
- Emerging infections in Asia 2008Springer
- Emerging therapeutic options for hepatitis C 2013Future MedHepatitis C virus infection : from discovery to eradication / Masao Omata & Tatsuo Kanda -- Interferons in clinical trials / Tatsuo Kanda, Osamu Yokosuka & Masao Omata -- Protease inhibitors / Marion Corouge, Philippe Sogni & Stanislas Pol -- NS5A inhibitor : daclatasvir / Kazuaki Chayama & C. Nelson Hayes -- Toll-like receptor agonists for nonresponders to HCV treatment : hope versus promise? / Valérie Martel-Laferrière & Douglas Dieterich -- Treatment options in HIV-HCV-coinfected patients / Philippe Sogni, Marion Corouge & Stanislas Pol -- Treatment options for dual HCV/HBV coinfection / Chun-Jen Liu & Jia-Horng Kao -- HCV treatment in patients with metabolic syndrome / Luigi E. Adinolfi, Rosa Zampino, Luciano Restivo, Amedeo Lonardo & Paola Loria -- Future directions in hepatitis C therapy / Stevan A. Gonzalez -- Index.
- Emerging viral diseases of Southeast Asia 2007KargerThe Singapore contribution in the battle against the severe acute respiratory syndrome / Fielding, B.C., Tan, Y.-J. -- Avian influenza in Thailand / Puthavathana, P. ... [et al.] -- Emerging viral diseases of fish and shrimp / Wang, M. ... [et al.] -- Avian influenza H5N1 virus: an emerging global pandemic / Lal, S.K., Chow, V.T.K. -- Henipaviruses: new threats for Southeast Asia and Australia / McCormack, J., Smith, G. -- Ross River virus: an arthritogenic alphavirus of significant importance in the Asia Pacific / Tupanceska, D. ... [et al.] -- Emerging and re-emerging infectious diseases in our global village / Heymann, D.L. -- Role of a pathology laboratory in SARS and other emerging infections / Nicholls, J., Peiris, J.S.M. -- The fight against emerging viral diseases in Asia / Lam, S.K.
- Epidemic of medical errors and hospital-acquired infections systemic and social causes 2012CRCnetBASE"'Do no harm' a particularly leading and important phrase in the delivery of healthcare is not working. In fact depending on the epidemiological approach and which data sets one applies, medical errors, hospital acquired infections (HAIs) and pharmaceutical errors combined are the second or third leading killer of Americans annually: approximately 300,000 die from a combination of medical errors, hospital acquired infections (HAIs), and pharmaceutical errors...100,000 per category. Add to these numbers the hundreds of thousands who are harmed (morbidity) but not killed (mortality) changing quality of life and a substantial problem is defined"--Provided by publisher.
- Epidemiological and molecular aspects on cholera 2011SpringerAsiatic cholera: mole hills and mountains -- Endemic and epidemic cholera in Africa -- Phenotypic and molecular characteristics of epidemic and non-epidemic vibrio cholerae strains isolated in Russia and certain countries of Commonwealth of Independent States (CIS) -- The re-emergence of cholera in the Americas -- The evolution of vibrio cholerae as a pathogen -- Molecular epidemiology of toxigenic vibrio cholerae -- Diversity and genetic basis of polysaccharide biosynthesis in vibrio cholerae -- Significance of the SXT/R391 family of integrating conjugative elements in vibrio cholerae -- Small molecule signaling systems in vibrio cholerae -- Vibrio cholerae flagellar synthesis and virulence -- Filamentous phages of vibrio cholerae O1 and O139 -- Pathogenic potential of non-O1, non-O139 vibrio cholerae -- Proteases produced by vibrio cholerae and other pathogenic vibrios: pathogenic roles and expression -- Toxins of vibrio cholerae and their role in inflammation, pathogenesis, and immunomodulation -- Vibrio cholerae hemolysin: an enigmatic pore-forming toxin -- Integrin-mediated antimicrobial resistance in vibrio cholerae -- Aquatic realm and cholera -- Management of cholera.
- 1. Early Concepts of Communicability -- 2. Infection on the Move -- 3. The Impact of Cholera -- 4. Stiffening the Sinews -- 5. Dawn and Sunset -- 6. A Need for Damage Limitation -- 7. No Lasting Stability -- 8. Tailpiece.
- Epidemiology and prevention of vaccine-preventable diseases the pink book : course textbook. 13th edition. 2015CDC
- Essential infectious disease topics for primary care 2008SpringerPart I. Upper Respiratory Tract Infections -- 1. Clinical guidelines: community acquired pneumonia / John Russell -- 2. Pharyngitis / Adrian Wilson -- 3. Treatment and management of acute otitis media / Ross H. Albert and Neil S. Skolnik -- 4. Management of chronic obstructive pulmonary disease exacerbations and acute bronchitis / Michael Gagnon -- 5. Latent tuberculosis infection: testing and treatment / Pamela Ann Fenstemacher -- 6. Sinusitis / Megan Werner and Mathew Clark -- Part II. Gastrointestinal Infections -- 7. Gastroenteritis / Andrew Deroo and Matthew Mintz -- 8. Hepatitis / Michele Lamoreux -- III. Sexually Transmitted Diseases -- 9. Sexually transmitted diseases / Neil Skolnik -- 10. Human immunodeficiency virus / Rosemary Harris -- IV. Skin, Bone, and Joint Infection -- 11. Cellulitis and skin infections associated with bites / Steven Zinn and Judith O'Donnell -- 12. Diabetic foot infections / Thomas C. McGinley Jr. -- 13, Osteomyelitis / Kelly Gannon and Todd Braun -- 14. Septic arthritis and infectious bursitis / Gene Hong and Nirandra Mahamitra -- 15. Lyme disease prevention, diagnosis, and treatment / Ross Albert and Neil Skolnik -- V. Other Infectious Disease Topics -- 16. Infective endocarditis / Tina Degnan and Neil Skolnik -- 17. Meningitis / Anne T. Wiedemann -- 18. Urinary tract infections / Jennifer Neria and Matthew Mintz -- 19. Adult immunizations / John Russell and Ross Albert -- 20. Clinical ethics and infectious disease in family medicine / Janet Fleetwood.
- Evidence-based neonatal infections 2014WileyHow to search for evidence -- Epidemiology -- Clinical manifestations -- Laboratory tests -- Rational antibiotic use -- Adjunctive treatment -- Bacterial meningitis -- Respiratory tract infections -- Osteomyelitis and septic arthritis -- Urinary tract infections -- Necrotizing enterocolitis and gastrointestinal infections -- Eye infections -- Skin and soft tissue infections -- Bacterial infections -- Mycoplasmas -- Fungal infections -- Viral infections -- Other congenital infections -- Breast milk -- Surveillance -- Infection control -- Developing countries -- Prevention of neonatal infections -- Neonatal antimicrobials.
- Feigin and Cherry's Textbook of pediatric infectious diseases. Seventh edition. [7th ed.] 2014ClinicalKeyFeigin and Cherry's Textbook of Pediatric Infectious Diseases helps you put the very latest knowledge to work for your young patients with unparalleled coverage of everything from epidemiology, public health, and preventive medicine through clinical manifestations, diagnosis, treatment, and much more. Ideal for all physicians, whether in an office or hospital setting, Feigin and Cherry's equips you with trusted answers to your most challenging clinical infectious disease questions. Meet your most difficult clinical challenges in pediatric infectious disease, including today's more aggressive infectious and resistant strains as well as emerging and re-emerging diseases, with unmatched, comprehensive coverage of immunology, epidemiology, public health, preventive medicine, clinical manifestations, diagnosis, treatment, and much more. Find the answers you need quickly thanks to an organization both by organ system and by etiologic microorganism, allowing you to easily approach any topic from either direction. Search the complete text and download all of the images online at Expert Consult.
- "These guidelines have been written for public health practitioners, food and health inspectors, district and national medical officers, laboratory personnel and others who may undertake or participate in the investigation and control of foodborne disease outbreaks."--P. 4 of cover.
- Foodborne pathogens hazards, risk analysis, and control 2002CRCnetBASE
- Foot and mouth disease the 1967 outbreak and its aftermath 2003Wellcome Trust
- Function and control of the Spx-family of proteins within the bacterial stress response 2013SpringerThis SpringerBrief on Spx reviews the investigations that led to the discovery of Spx and its orthologs and ties together the results of various studies that have explored the function and control of spx in Gram-positive organisms. Spx of Bacillus subtilis has been extensively studied, but very little has been published about it. This book incorporates a number of studies that have been conducted in other Gram positive bacteria, which examined the role of Spx orthologs in stress response, bacterial development and virulence. The book contains an overview that will introduce the protein and its orthologous forms, its association with RNA polymerase, the species of Gram-positive bacteria in which it is found, and the conditions in which it is abundant and active. Spx is a member of a large group of proteins belonging to the ArsC/Spx protein family, so the review touches upon the bioinformatic support for the protein family composition and its meaning with regard to protein structure/function.
- Over the past decade, significant progress has been made in the theory and applications of pharmacodynamics of antimicrobial agents. On the basis of pharmacokinetic-pharmacodynamic modeling concepts it has become possible to describe and predict the time course of antimicrobial effects under normal and pathophysiological conditions. The study of pharmacokinetic-pharmacodynamic relationships can be of considerable value in understanding drug action, defining optimal dosing regimens, and in making predictions under new or changing pre-clinical and clinical circumstances. Not surprisingly, pharmacokinetic-pharmacodynamic modeling concepts are increasingly applied in both basic and clinical research as well as in drug development. Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics is designed as a reference on the application of pharmacokinetic-pharmacodynamic principles for the optimization of antimicrobial therapy, namely pharmacotherapy, and infectious diseases. The reader is introduced to various aspects of the fundamentals of antimicrobial pharmacodynamics, the integration of pharmacokinetics with pharmacodynamics for all major classes of antibiotics, from basic research to clinical situations.
- "Using the two-page, templated organization of the 5-Minute Consult series, Gorbach's 5-Minute Infectious Diseases Consult, Second Edition provides comprehensive coverage for clinicians dealing with infectious diseases. The two major sections of the book cover chief complaints and individual diseases and disorders. Additional materials include summary information about individual microorganisms as well as numerous elements related to drugs for infectious disorders. A team of international authorities provides actionable information, supported by current research and practice guidelines.Features Include: Comprehensive coverage of infectious diseases, important symptoms, microorganisms, and anti-infective drugs Coverage of emerging infectious diseases such as H1N1 flu Increased coverage of tropical diseases Two-page, tightly written chapters Updated information about management of HIV/AIDS "--Provided by publisher.
- Grand challenge for the future vaccines for poverty-related diseases from bench to field 2005Springer
- "Preface Almost 1,800 media are described in the Handbook of Media for Clinical and Public Health Microbiology, including newly described media for the cultivation of emerging pathogens. Diseases caused by emerging pathogens that are responsible for increased rates of morbidity and mortality rates, such as Escherichia coli O157:H7, methicillin resistant Staphylococcus aureus (MRSA), vancomycin resistant enterococci (VRE), and carbapenem resistant enterococci (CRE) have raised special concerns and various media included in the Handbook have been designed for the specific cultivation and identification of these pathogens. Many of the new media included in the Handbook of Media for Clinical and Public Health Microbiology permit the cultivation of bacteria, fungi, and viruses that are currently causing major medical problems around the world. These media are very important for the rapid detection of pathogenic microorganisms and the diagnosis of individuals with specific infectious diseases adn for preventing the spread of pathogens via food, water, and environmental sources. Several of the new media described in the Handbook of Media for Clinical and Public Health Microbiology include chromogenic or fluorogenic substrates that permit the rapid detection of specific pathogens. An important function of the Handbook of Media for Clinical and Public Health Microbiology is to provide descriptions of the media that are used to cultivate and identify microorganisms from clinical specimens and those of public health significance. The Handbook provides a compilation of the formulations, methods of preparation, and applications for media used in clinical and public health microbiology laboratories"--Provided by publisher.
- HCV infection and cryoglobulinemia 2012SpringerHepatitis C virus infection and the role of the immune system -- Cryoglobulinemia: immunochemical characterization, serological abnormalities and histopathological changes -- Structural and genetic features, cytokines and chemokines in cryoglobulinemia -- Cellular compartments of HCV infection (and replication) -- Mechanism(s) of cryoprecipitation -- Clinical manifestations of cryoglobulinemia -- HCV infection, cryoglobulinemia and non-Hodgkin's lymphomas -- Therapy of cryoglobulinemia.
- Heat shock proteins of malaria 2014SpringerThe Importance of Molecular Chaperones in Survival and Pathogenesis of the Malaria Parasite Plasmodium falciparum / Jude Przyborski -- General Structural and Functional Features of Molecular Chaperones / Adrienne L. Edkins and Aileen Boshoff -- The Role of Hsp70s in the Development and Pathogenicity of Plasmodium Species / Addmore Shonhai -- Role of the Hsp40 Family of Proteins in the Survival and Pathogenesis of the Malaria Parasite / Eva-Rachele Pesce, Alexander G. Maier and Gregory L. Blatch -- Role of Hsp90 in Plasmodium falciparum Malaria / Dea Shahinas and Dylan R. Pillai -- The Role of Parasite Heat Shock Proteins in Protein Trafficking and Host Cell Remodeling / Paul R. Gilson, Sarah C. Charnaud and Brendan S. Crabb -- Role of Heat Shock Proteins in Immune Modulation in Malaria / Evelyn Böttger and Gabriele Multhoff -- Establishment of Plasmodium falciparum Extracellular Compartments in its Host Erythrocyte / Alassane Mbengue, Laurence Berry and Catherine Braun-Breton -- Chaperones and Proteases of Plasmodium falciparum / Kaiyin Liu and Walid A. Houry -- Heat Shock Proteins as Targets for Novel Anti-Malarial Drugs / Manish Grover, Shweta Chaubey and Utpal Tatu -- Heat Shock Proteins of Malaria: What Do We Not Know, and What Should the Future Focus Be? / Addmore Shonhai and Gregory L. Blatch.
- Hematology, immunology and infectious disease neonatology questions and controversies. 2nd ed. 2012ScienceDirect2012 ClinicalKeyUpdated information on stem cells for the neonatologist -- Current issues in the pathogenesis, diagnosis, and treatment of neonatal thrombocytropenia -- Role of recombinant leukocyte colony-stimulating factors in the neonatal intensive care unit -- Nonhematopoietic effects of erythropoietin -- Why, when, and how should we provide red cell transfusions and erythropoiesis-stimulating agents to support red cell mass in neonates? -- Diagnosis and treatment of immune-mediated and non-immune-mediated hemolytic disease of the newborn -- Hematology and immunology: coagulation disorders -- A practical approach to the neutropenic neonate -- What evidence supports dietary interventions to prevent infant food hypersensitivity and allergy? -- Maternally mediated nenonatal autoimmunity -- CMV: diagnosis, treatment, and considerations on vaccine-mediated prevention -- Neonatal T cell immunity and its regulation by innate immunity and dendritic cells -- Breast milk and viral infection -- Probiotics for the prevention of necrotizing enterocolitis in preterm neonates -- The ureplasma conundrum: should we look or ignore? -- Control of antibiotic-resistant bacteria in the neonatal intensive care unit -- Neonatal fungal infections -- The use of biomarkers for detection of early-and late-onset neonatal sepsis -- Chorioamnionitis and its effects on the fetus/neonate: emerging issues and controversies.
- Molecular biology of varicella-zoster virus / Rahaus, M., Desloges, N., Wolff, M.H -- Latency and reactivation of VZV / Lungu, O., Gershon, A.A. -- Laboratory confirmation of herpes zoster / Ludwig, B., Buxbaum, S., Doerr, H.W. -- Clinical picture and complications of herpes zoster: the view of the dermatologist / Gross, G. -- Ophthalmic manifestations of herpes zoster infection / Guembel, H. -- (Herpes) zoster oticus / Pau, H.W. -- Neuroanatomy of pain and neuropathology of herpes zoster and postherpetic neuralgia / Wree, A., Usunoff, K.G. -- Postherpetic neuralgia and other neurologic complications / Baron, R. -- Varicella-zoster virus infections during pregnancy / Sauerbrei, A., Wutzler, P. -- Herpes zoster in the immunocompromised host / Schöfer, H. -- Chickenpox and zoster in marrow transplant recipients / Genvresse, I., Maschmeyer, G. -- General aspects of therapy / Gross, G. -- Antiviral therapy of shingles in dermatology / Lilie, H.M., Wassilew, S.W. -- Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d] pyrimidine nucleoside analogues (BCNAS) / Clercq, E.D. -- Therapy of zoster pain, postherpetic neuralgia and other neurological complications / Baron, R. -- Epidemiology of herpes zoster: what has changed? / Allwinn, R., Buxbaum, S., Doerr, H.W. -- Live attenuated varicella vaccine / Gershon, A.A.
- Section I. Applied epidemiology and biostatistics in healthcare epidemiology and infection control -- Section II. Healthcare quality improvement -- Section III. Informatics in healthcare epidemiology -- Section IV. Epidemiology and prevention of healthcare-associated infections of organ systems -- Section V. Epidemiology and prevention of healthcare-associated infections caused by specific pathogens -- Section VI. Epidemiology and prevention of healthcare-associated infections in pediatric patients -- Section VII. Epidemiology and prevention of healthcare-associated infections in special patient populations -- Section VIII. Epidemiology and prevention of healthcare-associated infections related to diagnostic and therapeutic procedures -- Section IX. Prevention of healthcare-associated infections related to the hospital environment -- Section X. Epidemiology and prevention of healthcare-associated infections in healthcare workers -- Section XI. Disinfection and sterilization -- Section XII. Prevention of infectsions acquired by patients in healthcare facilities related to design, construction, renovation, demolition and ventilation systems -- Section XIII. Antimicrobial agents in healthcare epidemiology and infection control -- Section XIV. Literature in healthcare epidemiology and infection control -- Section XV. Organization and implementation of infection control programs -- Section XVI. Healthcare epidemiology and infection control in special settings for healthcare delivery -- Section XVII. Bioterrorism.
- Hospital infection prevention principles & practices 2014SpringerThe art of medicine becomes science when supported by evidence. The recommended practices of infection prevention are based on scientific and epidemiologic evidence. However,most health care professionals see them as mandates and fail to incorporate them into their routine patient care activities. Thecore goal of this publication is to link the practices to theprinciples they are based on. The expectation is that understanding ofthe principles willchange thepractices from mandates to "should do" in the minds of health care professionals. This will lead to improvement inhealth care by preventing unintended harm to patients, co-workers and the communities at large. At the same time, the text provides a comprehensive, thorough and up to date information on all aspects of infection prevention in a reader-friendly manner and therefore, will serve as a valuable reference.
- Hospital-acquired pneumonia 2013Future MedHospital-acquired pneumonia / Ilias I. Siempos -- Risk factors / Simone Gattarello, Despoina Koulenti & Jordi Rello -- Etiology and pathophysiology of hospital-acquired pneumonia / Ian Weir, Luciano Silvestri & Hendrick K.F. van Saene -- Symptoms, diagnosis and prognosis / Despoina Koulenti & Alexis Tabah -- Ventilator-associated pneumonia / Jana Hudcova & Donald E. Craven -- Prevention as a key measure to improve healthcare quality and patient safety / Dominique M. Vandijck, Stijn I. Blot, Sonia O. Labeau & Dirk P. Vogelaers -- Guidelines for the management of hospital-acquired pneumonia / Adamantia Liapikou -- Index.
- Hot topics in infection and immunity in children. IX 2013Springer
- Development of the First AIDS Drugs: AZT and Other Dideoxynueosides / Robert Yarchoan, Hiroaki Mitsuya -- Part I: Structure and Function of HIV RT. Proviral DNA Synthesis in HIV: Background / Dorota Piekna-Przybylska Ph.D., Robert A. Bambara Ph.D. -- The RNase H Domain: Structure, Function and Mechanism / Marcin Nowotny, Małgorzata Figiel -- Conformational Dynamics of Reverse Transcription / Stuart F. J. LeGrice -- Part II: Mechanism of Action of Approved RT Inhibitors. Nucleoside RT Inhibitors: Structural and Molecular Biology / Gaofei Lu, Antonio J. Acosta-Hoyos, Walter A. Scott -- Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) / Kalyan Das Ph.D., Eddy Arnold Ph.D., Stephen H. Hughes Ph.D. -- Part III: Alternative Strategies to Interfere with the Function of HIV RT. Ribonuclease H Inhibitors: Structural and Molecular Biology / Jason W. Rausch -- Targeting Small Molecules and Peptides to the p66-p51 Reverse Transcriptase Interface / Daouda Abba Moussa, Audrey Agopian, Gilles Divita -- Targeting RT Translocation / Gregory L. Beilhartz, Brian J. Scarth, Matthias Götte -- tRNA Primer Sequestration as an Antiviral Strategy / Christopher P. Jones, Karin Musier-Forsyth -- Part IV: HIV Genetic Variability and the Problem of Drug Resistance. HIV Reverse Transcriptase Fidelity, Clade Diversity, and Acquisition of Drug Resistance / Luis Menéndez-Arias -- APOBECs and Their Role in Proviral DNA Synthesis / John S. Albin, Reuben S. Harris -- Role of RNase H Activity in NRTI/NNRTI Drug Resistance / Gilda Tachedjian B.Sc. (Hons), Ph.D., Nicolas Sluis-Cremer B.Sc. (Hons), Ph.D. -- HIV Population Dynamics / Mary Kearney, John Coffin -- Part V: Prevention and Future Approaches. RT Inhibitors as Microbicides / Jan Balzarini.
- Human papillomavirus bench to bedside 2014Karger"Human papillomavirus (HPV) infection transcends multiple fields of science and medicine. The management of HPV-related disease is demanding and often requires a persistent multimodal approach involving various medical disciplines. In this volume, experts present a comprehensive view of HPV research with an emphasis on clinical presentations, diagnosis, management and vaccine development. The state of the art in molecular biology is provided in addition to discussions on clinical morphology and the utility of dermatoscopy in identifying HPV disease. In a multidisciplinary approach to dermatological, plastic and reconstructive, gynecological, otolaryngological and colorectal management, different treatment strategies are highlighted"--Publisher's description.
- Human papillomavirus vaccines 2011Future MedHuman papillomavirus vaccines / Eduardo L. Franco -- Pathobiology and immunology of human papillomavirus / Margaret Stanley -- Overview of clinical evidence : the quadrivalent vaccine Gardasil / Suzanne M Garland -- Overview of clinical evidence : Cervarix -- Tino F. Schwarz -- HPV vaccines : public health and clinical guidelines / F. Xavier Bosch -- Perspectives for prophylactic and therapeutic vaccination for HPV-induced lesions / Shreya Kanodia & W. Martin Kast.
- pt. 1. Clinical practice in the tropics -- pt. 2. Viral diseases -- pt. 3. Bacterial infections -- pt. 4. The mycoses -- pt. 5. Protozoal infections -- pt. 6. Helminthic infections -- pt. 7. Poisonous and toxic plants and animals -- pt. 8. Nutritional problems and deficiency diseases -- pt. 9. Vector transmission of diseases and zoonoses -- pt. 10. The sick returning traveler -- pt. 11. Laboratory diagnosis of parasitic diseases -- pt. 12. Drugs used in tropical medicine.
- Immunity and tolerance 2013Cold Spring Harb Lab PressDevelopment and antigen receptor gene assembly: TET proteins and 5-methylcytosine oxidation in the immune system / Ageliki Tsagaratou, Anjana Rao ; Control of antigen receptor diversity through spatial regulation of V(D)J recombination / Anja Ebert, Jasna Medvedovic, Hiromi Tagoh, Tanja A. Schwickert, Meinrad Busslinger ; Establishment and maintenance of B cell identity / Rudolf Grosschedl ; Transcriptional establishment of cell-type identity : dynamics and causal mechanisms of T-cell lineage commitment / Ellen V. Rothenberg, Ameya Champhekar, Sagar Damle, Marissa Morales Del Real, Hao Yuan Kueh, Long Li, Mary A. Yui ; The epigenetics of early lymphocyte development / C. Murre -- Gene regulation: Regnase-1, a ribonuclease involved in the regulation of immune responses / Shizuo Akira ; Toward an understanding of the gene-specific and global logic of inducible gene transcription / Stephen T. Smale, Scott E. Plevy, Amy S. Weinmann, Liang Zhou, Vladimir R. Ramirez-Carrozzi, Scott D. Pope, Dev M. Bhatt, Ann-Jay Tong ; Tolerization of inflammatory gene expression / John J. Seeley, Sankar Ghosh -- The 'histone mimicry' by pathogens / Uwe Schaefer, Jessica S.Y. Ho, Rab K. Prinjha, Alexander Tarakhovsky -- Development and function of myeloid subsets: Myb-independent macrophages : a family of cells that develops with their tissue of residence and is involved in its homeostasis / Elisa Gomez Perdiguero, Frederic Geissmann ; The molecular choreography of IRF4 and IRF8 with immune system partners / Harinder Singh, Elke Glasmacher, Abraham B. Chang, Bryan Vander Lugt -- The IRF family transcription factors at the interface of innate and adaptive immune responses / Hiroaki Ikushima, Hideo Negishi, Tadatsugu Taniguchi -- T-cell differentiation and function: IL-1b strikingly enhances antigen-driven CD4 and CD8 t-cell responses / S.Z. Ben-Sasson, K. Wang, J. Cohen, W.E. Paul ; A modified model of t-cell differentiation based on mTOR activity and metabolism / Jonathan D. Powell, Emily B. Heikamp, Kristen N. Pollizzi, Adam T. Waickman ; Novel tools to dissect the dynamic regulation of TCR signaling by the kinase Csk and the Phosphatase CD45 / Ying Xim Tan, Julie Zikherman, Arthur Weiss -- NK cells and innate lymphoid cells: Dissection of signaling in inflammation : three novel inflammatory regulators / Thorsten Berger, Mary E. Saunders, Tak W. Mak ; Tissue-resident natural killer cells / Wayne M. Yokoyama, Dorothy K. Sojka, Hui Peng, Zhigang Tian -- Microbial immunity: Immunology taught by human genetics / Jean-Laurent Casanova, Laurent Abel, Lluis Quintana-Murci ; Systems approach to understand the immune response in tuberculosis : an iterative process between mouse models and human disease / Anne O'Garra ; The zebrafish guide to tuberculosis immunity and treatment / Lalita Ramakrishnan ; Microbiota : host interactions in mucosal homeostasis and systemic autoimmunity / Randy S. Longman, Yi Yang, Gretchen E. Diehl, Sangwon V. Kim, Dan R. Littman ; The promised land of human immunology / Laura F. Su, Arnold Han, Helen M. McGuire, David Furman, Evan W. Newell, Mark M. Davis -- Tolerance, TREGS, and inflammasome: Transcriptional control of regulatory t-cell differentiation / Joris van der Veeken, Aaron Arvey, Alexander Rudensky -- miR-181 and metabolic regulation in the immune system / Adam Williams, Jorge Henao-Mejia, Christian C.D. Harman, Richard A. Flavell ; Encoding immunological memory in the initiation of b-cell receptor signaling / Susan K. Pierce, Wanli Liu -- Tumor immunology and genome stability: Programmed cell death 1-directed immunotherapy for enhancing t-cell function / Koichi Araki, Ben Youngblood, Rafi Ahmed ; Immune surveillance of unhealthy cells by natural killer cells / Alexandre Iannello, David H. Raulet ; Studying Epstein-Barr virus pathologies and immune surveillance by reconstructing EBV infection in mice / Tomoharu Yasuda, Tristan Wirtz, Baochun Zhang, Thomas Wunderlich, Marc Schmidt-Supprian, Thomas Sommermann, Klaus Rajewsky -- Closing lecture: Pathogen-sensing, regulatory t cells, and responsiveness-tuning collectively regulate foreign- and self-antigen mediated t-cell responses / William E. Paul, Joshua D. Milner, Zvi Grossman.
- Immunology and evolution of infectious disease 2002NCBI Bookshelf
- Harrison's Principles of Internal Medicine
- AAP Red Book Online
- Robbins & Cotran Pathologic Basis of Disease
- Sabiston Textbook of Surgery
- Nelson's Textbook of Pediatrics
- Surgical Exposures in Orthopaedics
- Mandell, Douglas, & Bennett's Principles & Practice of Infectious Diseases
- Red Book Online
- ICU Book
- Primary Care Medicine
- Campbell-Walsh Urology
Access restricted to Stanford community
Shortcut to Licensed Content
TO INSTALL, DRAG THIS BUTTON to your browser Bookmarks or Tools Bar.
Bookmark on Other Websites
- TO INSTALL, RIGHT CLICK this button.
- Select "Add to Favorites" (click “Continue” if you see a security alert)
- From the "Create in" menu, select “Favorites Bar” (IE8, IE9) to install
- Once installed it will look like this
- Click "Bookmark on Lane" to bookmark any webpage
- Your saved bookmark will appear on this page
TO INSTALL, RIGHT CLICK this button.
Can't find it?
Look if we have it in print
- Springer Protocols
- Lange Series
- National Academy Press
- NCBI Bookshelf
- Thieme Atlases
Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities. In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities. In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.Large number of high quality software and database programming titles from O'Reilly. Other software titles are also available from Sams and Prentice Hall. Limited to 7 concurrent users.Vast collection of software and database programming titles from multiple publishers, including Microsoft Press.Largest provider of engineering-related eBooks; includes titles in computer science and biomedical engineering.Over 4,000 full-text e-books covering scientific and technical information from CRC Press and others. Many handbooks and single volume reference sources.A repository of medical knowledge from internal medicine, cardiology, genetics, pharmacy, diagnosis and management, basic sciences, patient care, and more. Continuously expanding, all databases in the repository contain the latest editions of selected medical titles.Includes peer-reviewed life science and biomedical research protocols compiled from Methods in Molecular Biology, Methods in Molecular Medicine, Methods in Biotechnology, Methods in Pharmacology and Toxicology, Neuromethods, the Biomethods Handbook, the Proteomics Handbook, and Springer Laboratory Manuals.Contains full text access to selected biomedical and nursing books.Provides one-click access to important clinical resources; includes evidence-based diagnosis and treatment guidelines, Books, EBM articles, Ovid MEDLINE, Drug facts and comparisons, Drug interaction facts, guidelines from National Guideline Clearinghouse, patient handouts (English and Spanish), and local content.ClinicalKey provides access to textbooks, electronic journals, practice guidelines, drug information, and patient education handouts.A collection of biomedical books that can be searched directly by concept, and linked to terms in PubMed abstracts.Provides online, full-text access to Springer's journal titles as well as journals from other publishers. Subjects include: life sciences, chemical sciences, environmental sciences, geosciences, computer science, mathematics, medicine, physics and astronomy, engineering and economics. Also includes eBooks.Collection of over 8 thousand fulltext titles in engineering, math, and basic and applied biomedical research. Coverage is from 1967 to the present.A library of ebooks on a wide array of topics, digitized and made available online in conjunction with the original publishers.